drugset / Trial / NCT02447601

Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects

NCT02447601

Phase 1 Completed 16 enrolled Jiangsu Hansoh Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelOther

Summary

To assess the effect of PEX168 doses on the pharmacokinetics of simvastatin(as determined by simvastation acid) in healthy subjects. To assess the safety of single doses of simvastation administered with and without PEX168

Timeline

Start
2015-03-30
Primary completion
2015-05-14
Completion
2015-08-11

Drugs

EvaluationDrugModalityDoseRoute
Subject PEGLOXENATIDE Peptide 200 ug Subcutaneous
Subject Simvastatin Small molecule 40 mg Oral